Skip to main content
SpringerLink
Log in

Neurochemical Imaging with Emission Tomography: Clinical Applications

  • Chapter
Book cover Diagnostic Nuclear Medicine

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M et al (2000) Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 20:225–243

    CAS  PubMed  Google Scholar 

  • Abou-Khalil BW, Siegel GJ, Sackellares JC, Gilman S, Hichwa R, Marshall R (1987) Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol 22:480–486

    Article  CAS  PubMed  Google Scholar 

  • Albin RL, Minoshima S, D’Amato CJ, Frey KA, Kuhl DE, Sima AAF (1996) Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47:462–466

    CAS  PubMed  Google Scholar 

  • Alexandrov AV, Masdeu JC, Devous MD Sr, Black SE, Grotta JC (1997) Brain single-photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemic stroke. Proceedings of the meeting of the SPECT Safe Thrombolysis Study Collaborators and the members of the Brain Imaging Council of the Society of Nuclear Medicine. Stroke28:1830–1834

    CAS  PubMed  Google Scholar 

  • Andersen AR, Gram L, Kjaer L, Fuglsang-Frederiksen A, Herning M, Lassen NA, Dam M (1988) SPECT in partial epilepsy: identifying side of the focus. Acta Neurol Scand 78[Suppl 117]:90–95

    Google Scholar 

  • Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL (1997) Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12:33–38

    Article  CAS  PubMed  Google Scholar 

  • Arnett CD, Fowler JS, MacGregor RR (1987) Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-11C deprenyl. J Neurochem 49:522–527

    CAS  PubMed  Google Scholar 

  • Atlas SW (1991) Intraaxial brain tumours. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Raven, New York, pp 379–409

    Google Scholar 

  • Baron JC; Bousser MG; Comar D; Soussaline F; Castaigne P (1981) Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol 20:273–284

    CAS  PubMed  Google Scholar 

  • Baronti F, Conant KE, Giuffra M, Davis TL, Brughitta G, Iadarola M, Berrettini WH, Chase TN, Mouradian MM (1991) Opioid peptides in Parkinson’s disease: effects of dopamine repletion. Brain Res 560:92–96

    Article  CAS  PubMed  Google Scholar 

  • Barrington SF, Koutroumanidis M, Agathonikou A, Marsden PK, Binnie CD, Polkey CE, Maisey MN, Panayiotopoulos CP (1998) Clinical value of “ictal” FDG-positron emission tomography and the routine use of simultaneous scalp EEG studies in patients with intractable partial epilepsies. Epilepsia 39:753–766

    Article  CAS  PubMed  Google Scholar 

  • Bartenstein P, Ludolph A, Schober O, Lottes G, Scheidhauer K, Sciuk J, Beer H-F (1993) Benzodiazepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med 18:111–118

    Google Scholar 

  • Baumgartner C, Serles W, Leutmezer F, Pataraia E, Aull S, Czech T, Pietrzyk U, Relic A, Podreka I (1998) Preictal SPECT in temporal lobe epilepsy: regional cerebral blood flow is increased prior to electroencephalography-seizure onset. J Nucl Med 39:978–982

    CAS  PubMed  Google Scholar 

  • Beer HF, Bläuenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, Hunkeler W, Bonetti EP, Pieri L, Richards JG, Schubiger PA (1990) In vitro and in vivo evaluation of iodine-123-Ro16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31:1007–1014

    CAS  PubMed  Google Scholar 

  • Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY (1983) The fluorodeoxyglucose-18F scan in Alzheimer’s disease and multi-infarct dementia. Arch Neurol 40:711–714

    CAS  PubMed  Google Scholar 

  • Bergstrom M, Muhr C, Lundberg PO, Berstrom K, Lundqvist H, Antoni G, Fasth K-G, Langstrom B (1987) In vivo study of amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with 11CD-methionine and 11C-L-methionine. J Comput Assist Tomogr 11:384–389

    CAS  PubMed  Google Scholar 

  • Bergstrom M, Muhr C, Jossan S, Lilja A, Nyberg G, Langstrom B (1992) Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and[11C ]-L-deprenyl. Neurosurgery 30:855–861

    CAS  PubMed  Google Scholar 

  • Berridge M, Comar D, Crouzel C, Baron JC (1983) 11C-Labelled ketanserin: a selective serotonin S2 antagonist. J Label Compds Radiopharm 20:73

    CAS  Google Scholar 

  • Biersack HJ, Coenen HH, Stocklin G, Reichmann K, Bockisch A, Oehr P, Kashab M, Rollmann O (1989) Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 30:110–112

    CAS  PubMed  Google Scholar 

  • Biousse V, Zilovicius M, De Recondo A, Woimant F, Amarenco P, Bousser MG et al (1993) PET study of central benzodiazepine receptors (BZR) with [11C]-flumazenil (Cflu) distinguishes “functional” from structural hypometabolism in stroke. Neurology 43:A381

    Google Scholar 

  • Blum DE, Ehsan T, Dungan D, Karis JP, Fisher RS (1998) Bilateral temporal hypometabolism in epilepsy. Epilepsia 39:651–659

    Article  CAS  PubMed  Google Scholar 

  • Bohnen NI, Frey KA (2003) The role of positron emission tomography imaging in movement disorders. Neuroimag Clin North Am 13:791–803

    Google Scholar 

  • Bonte FJ, Stokely EM, Devous MD Jr, Homan RW (1983) Singlephoton tomographic study of regional cerebral blood flow in epilepsy. A preliminary report. Arch Neurol 40:267–270

    CAS  PubMed  Google Scholar 

  • Brooks DJ, Salmon EP, Mathias CJ, Quinn N, Leenders KL, Bannister R, Marsden CD, Frackowiak RSJ (1990a) The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson’s disease, studied with PET. Brain 113:1539–1552

    PubMed  Google Scholar 

  • Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RSJ (1990b) Differing patterns of striatal 18F-dopa uptake in Parkinson’s disease, multiple system atrophy, and progressive supra-nuclear palsy (see comments). Ann Neurol 28:547–555

    Article  CAS  PubMed  Google Scholar 

  • Brooks DJ, Ilbanez V, Sawle GV, Plaayford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RSJ (1992a) Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 31:184–192

    Article  CAS  PubMed  Google Scholar 

  • Brooks DJ, Playford ED, Ibanez V, Sawle GV, Thompson PD, Findley L, Marsden CD (1992b) Isolated tremor and disruption of the nigrostriatal system: an 18F-dopa PET study (see comments). Neurology 42:1554–1560

    CAS  PubMed  Google Scholar 

  • Brucke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I (1993) SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 94:137–146

    CAS  PubMed  Google Scholar 

  • Buck A, Westera G, Sutter M, Albani C, Kung HF, von Schulthess GKJ (1995) Iodine-123-IBF SPECT evaluation of extrapyramidal diseases. J Nucl Med 36:1196–1200

    CAS  PubMed  Google Scholar 

  • Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE et al (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461–467

    Article  CAS  PubMed  Google Scholar 

  • Choksey MS, Costa DC, Iannotti F, Ell PJ, Chochard HA (1989) Tc-99m-HMPAO SPECT and cerebral blood flow: a study of CO2 reactivity. Nucl Med Commun 10:609–618

    CAS  PubMed  Google Scholar 

  • Coenen HH, Laufer P, Stocklin G, Wienhard K, Pawlik G, Bocker-Schwarz HG, Heiss WD (1987) 3-N-(2‘[18F]fluoroethyl)spiperone: a new ligand for cerebral dopamine receptor studies with PET. Life Sci 40:81–88

    Article  CAS  PubMed  Google Scholar 

  • Cordes M, Christe W, Henkes H, Delavier U, Eichstädt H, Schörner W, Langer R, Felix R (1990) Focal epilepsies: HMPAO SPECT compared with CT, MR, and EEG. J Comput Assist Tomogr 14:402–409

    CAS  PubMed  Google Scholar 

  • Costa DC, Gacinovic S, Miller RF (1995) Radionuclide brain imaging in acquired immunodeficiency syndrome (AIDS). Q J Nucl Med 39:243–249

    CAS  PubMed  Google Scholar 

  • Crouzel C, Venet M, Irie T, Sanz G, Boullais C (1988) Labelling of a serotonergic ligand with 18F: [18F]setoperone. J Label Compds Radiopharm 25:403

    CAS  Google Scholar 

  • Cumming P, Gjedde A (1998) Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 29:37–61

    Article  CAS  PubMed  Google Scholar 

  • Cutler NR, Haxby JV, Duara R, Grady CL, Kay AD, Kessler RM, Sundaram M, Rapoport SI (1985) Clinical history, brain metabolism, and neuropsychological function in Alzheimer’s disease. Ann Neurol 18:298–309

    Article  CAS  PubMed  Google Scholar 

  • Daemen BJ, Zwertbroek R, Elsinga PH, Paans AM, Doorenbos H, Vaalburg W (1991) PET studies with L-[11C]tyrosine, L-[metyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocriptine treatment. Eur J Nucl Med 18:453–460

    Article  CAS  PubMed  Google Scholar 

  • D’Amico A, Messa C, Castagna A, Zito F, Galli L, Pepe G, Lazzarin A, Lucignani G, Fazio F (1997) Diagnostic accuracy and predictive value of 201-Tl SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 18:741–750

    CAS  PubMed  Google Scholar 

  • Dannals RF, Neumeyer JL, Milius RAJ, Ravert HT, Wilson AA, Wagner HN (1993) Synthesis of a radiotracer for studying dopamine uptake sites in vivo using PET: 2B-carbomethoxy-3B-(4-fluorophenyl)-[N-11C-methyl]-tropane (11C)CFT or (11C)-WIN 35,428. J Label Compounds Radiopharmacol 33:147–152

    CAS  Google Scholar 

  • Davis S, Andrews J, Lichenstein M, Kaye A, Tress B, Rossiter S, Salehi N, Binns D (1990) A Single-photon emission computed tomographay study of hypoperfusion after sub-arachnoid hemorrhage. Stroke 21:252–259

    CAS  PubMed  Google Scholar 

  • Debets RM, Sadzot B, van Isselt JW, Brekelmans GJ, Meiners LC, van Huffelen AO, Franck G, van Veelen CW (1997) Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 62:141–150

    CAS  PubMed  Google Scholar 

  • De Herder WWA, Reijs AEM, de Swart J, Kaandorp Y, Lamberts SWJ, Krenning EP, Kwekkeboom DJ (1999) Comparison of iodine-123 epidepride and iodine-123 IBZM for domapine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas. Eur J Nucl Med 26:46–50

    PubMed  Google Scholar 

  • Dey HM, Seibyl JP, Stubbs JB, Zoghbi SS, Baldwin RM, Smith EO, Zubal IG, Zea Ponce Y, Olson C, Charney DS (1994) Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123 iomazenil. J Nucl Med 35:399–404

    CAS  PubMed  Google Scholar 

  • Devous MD Sr, Leroy RF (1989) Comparison of interictal and ictal regional cerebral blood flow findings with scalp and depth electrode seizure focus localization. J Cereb Blood Flow Metab 9[Suppl]:S91

    Google Scholar 

  • Di Chiro G, Brooks RA (1988) PET-FDG of untreated and treated cerebral gliomas. J Nucl Med 29:421–422

    PubMed  Google Scholar 

  • Di Chiro G, De LaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnson GS, Manning RG, Wolf AP (1982) Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and positron emission tomography. Neurology 32:1323–1329

    PubMed  Google Scholar 

  • Di Chiro G, Oldfield E, Wright DC, de Michele G, Patronas N, Doppman JL, Larson SM, Masanori I, Kufta CV (1988) Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumours, PET and neuropathologic studies. Am J Roentgenol 150:189–197

    Google Scholar 

  • Diksic M, Tohyama Y, Takada A (2000) Brain net unidirectional uptake of a-methyltryptophan. Neurochem Res 25:1537–1546

    Article  CAS  PubMed  Google Scholar 

  • Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens I, de Deyn PP (1994) Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 21:621–633

    CAS  PubMed  Google Scholar 

  • Ding Y, Liu N, Wang T, Marecek J, Garza V, Ojima I et al (2000) Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidiny lmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. Nucl Med Biol 27:381–389

    CAS  PubMed  Google Scholar 

  • Dolle F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I et al (1999) Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidiny lmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. J Med Chem 42:2251–2259

    Article  CAS  Google Scholar 

  • Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y (1983) A subcortico-cortical cholinergic system is affected in Parkinson’s disease. Brain Res 288:213–218

    CAS  PubMed  Google Scholar 

  • Dubois B, Danze F, Pillon B, Cusimano G, Lhermitte F, Agid Y (1987) Cholinergic-dependent cognitive deficits in Parkinson’s disease. Ann Neurol 22:26–30

    Article  CAS  PubMed  Google Scholar 

  • Duncan JS (1997) Imaging and epilepsy. Brain 120:339–377

    Article  PubMed  Google Scholar 

  • Duncan R, Patterson J, Roberts R, Hadley DM, Bone I (1993) Ictal/postictal SPECT in the pre-surgical localization of complex partial seizures. J Neurol Neurosurg Psychiatry 56:141–148

    CAS  PubMed  Google Scholar 

  • Eckelman WC, Reba RC, Rzeszotarski WJ, Gibson RE, Hill T, Holman BL, Budinger T, Conklin JJ, Eng R, Grissom MP (1984) Cerebral imaging of acetylcholine muscarinic receptors. Science 223:291–293

    CAS  PubMed  Google Scholar 

  • Engel J Jr (1984) The use of positron emission tomographic scanning in epilepsy. Ann Neurol 15[Suppl]:S180–191

    PubMed  Google Scholar 

  • Engel J Jr (1988) Comparison of positron emission tomography and electroencephalography as measures of cerebral function in epilepsy. In: Pfurtscheller G, Lopes da Silva FH (eds) Functional brain imaging. Huber, Bern, pp 229–238

    Google Scholar 

  • Engel J Jr, Brown WJ, Kuhl DE, Phelps ME, Mazziotta JC, Crandall PH (1982a) Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 12:518–528

    PubMed  Google Scholar 

  • Engel J Jr, Kuhl DE, Phelps ME, Crandall PH (1982b) Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 12:529–537

    PubMed  Google Scholar 

  • Engel J Jr, Kuhl DE, Phelps ME (1982c) Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 218:64–66

    PubMed  Google Scholar 

  • Engel J Jr, Kuhl DE, Phelps ME, Rausch R, Nuwer M (1983) Local cerebral metabolism during partial seizures. Neurology 33:400–413

    PubMed  Google Scholar 

  • Engel J Jr, Henry TR, Risinger MW, Mazziotta JC, Sutherling WW, Levesque MF, Phelps ME (1990) Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 40:1670–1677

    PubMed  Google Scholar 

  • Ericson K, Lilja A, Bergstrom M, Collins VP, Eriksson L, Ehrin E, von Holst H, Lundqvist H, Langsrom B B, Mosskin M (1985) Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supra-tentorial tumors. J Comput Assist Tomogr 9:683–689

    CAS  PubMed  Google Scholar 

  • Feldman RS, Meyer JS, Quenzer LF (1997) Principles of neuropsychopharmacology. Sinauer Associates, Sunderland

    Google Scholar 

  • Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L (1989) Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 91:311–321

    Article  CAS  PubMed  Google Scholar 

  • Fishbein DS (1988) Neuroradiologic work-up of brain tumours. In: Theodore WH (ed) Clinical neuroimaging. Liss, New York, pp 111–137

    Google Scholar 

  • Fowler JS, MacGregor RR, Wolf AP Arnett CD, Dewey SL, Schlyer D, Christman D, Logan J, Smith M, Sachs H et al (1987) Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 235:481–485

    CAS  PubMed  Google Scholar 

  • Fowler JS, Volkow ND, Logan J, Schlyer DJ, MacGregor RR, Wang GJ, Wolf AP, Pappas N, Alexoff D, Shea C (1993) Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson’s disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327. Neurology 43:1984–1992

    CAS  PubMed  Google Scholar 

  • Frackowiak RSJ, Lenzi GL, Jones T, Heather JD (1980) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr 4:727–736

    CAS  PubMed  Google Scholar 

  • Franck G, Sadzot B, Salmon E, Depresseux JC, Grisar T, Peters JM, Guillaume M, Quaglia L, Delfiore G, Delmotte D (1986) Regional blood flow and metabolic rates in human focal epilepsy and status epilepticus. In: Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ (eds) Basic mechanisms of the epilepsies. Molecular and cellular approaches. Advances in neurology, vol 44. Raven, New York, pp 935–948

    Google Scholar 

  • Franck G, Maquet P, Sadzot B, Salmon E, Debets R, Dive D, Grisar T, Guillaume D, van Veelen C, van Huffelen A, van Emde Boas (1992) Contribution of positron emission tomography to the investigation of epilepsies of frontal lobe origin. In: Chauvel P, Delgado-Escueta AV et al (eds) Advances in neurology, vol 57. Raven, New York, pp 471–485

    Google Scholar 

  • Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S et al (1996) Presynaptic monoaminergic vesicles in Parkinson’s disease and normal aging. Ann Neurol 40:873–884

    Article  CAS  PubMed  Google Scholar 

  • Frey KA, Minoshima S, Kuhl DE (1998) Neurochemical imaging of Alzheimer’s disease and other degenerative dementias. Q J Nucl Med 42:166–178

    CAS  PubMed  Google Scholar 

  • Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Muesman RH, Derenzo SE (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 7:590–598

    CAS  PubMed  Google Scholar 

  • Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RS (1995) Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapp 2:189–210

    Google Scholar 

  • Frost JJ (1986) Measurement of neurotransmitter receptors by positron emission tomography: focus on the opiate receptor. NIDA Res Monogr 74:15–24

    CAS  PubMed  Google Scholar 

  • Frost JJ (2003) Molecular imaging of the brain: a historical perspective. Neuroimag Clin North Am 13:653–658

    Google Scholar 

  • Frost JJ, Smith AC, Wagner HN Jr (1986) 3H-diprenorphine is selective for mu opiate receptors in vivo. Life Sci 38:1597–1606

    Article  CAS  PubMed  Google Scholar 

  • Frost JJ, Mayberg HS, Fisher RS, Douglass KH, Dannals RF, Links JM, Wagner HN Jr (1988) Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 23:231–237

    Article  CAS  PubMed  Google Scholar 

  • Frost JJ, Mayberg HS, Sadzot B, Dannals RF, Lever JR, Ravert HT, Wilson AA, Wagner HN Jr, Links JM (1990) Comparison of [11C]carfentanil binding to opiate receptors in humans by positron emission tomography. J Cereb Blood Flow Metab 10:484–492

    CAS  PubMed  Google Scholar 

  • Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH, Ravert HT, Dannals RF (1993) Positron emission tomographic imaging of the dopamine transporter with 11CWIN 35,428 reveals marked declines in mild Parkinson’s disease. Ann Neurol 34:423–431

    Article  CAS  PubMed  Google Scholar 

  • Geraghty JJ, Jankovic J, Zetusky WJ (1985) Association between essential tremor and Parkinson’s disease. Ann Neurol 17:329–333

    Article  CAS  PubMed  Google Scholar 

  • Giobbe D, Castellano GC, Podio V (1993) Dopamine D2 receptor imaging with SPECT using IBZM in 16 patients with Parkinson’s disease. Ital J Neurol Sci 14:165–169

    CAS  PubMed  Google Scholar 

  • Giubilei F, Lenzi GL, di Piero V, Pozzilli C, Pantano P, Bastianello S, Argentino C, Fieschi C (1990) Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke 21:895–900

    CAS  PubMed  Google Scholar 

  • Gjedde A, Wong DF (1990) Modeling neuroreceptor binding of radioligands in vivo. In: Frost JJ, Wagner HN Jr (eds) Quantitative imaging: neuroreceptors, neurotransmitters, and enzymes. Raven, New York, pp 51–79

    Google Scholar 

  • Goldberg HI (1991) Extraaxial brain tumours. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Raven, New York, pp 327–377

    Google Scholar 

  • Grünwald F, Durwen HF, Bockisch A, Hotze A, Kersjes W, Elger CE, Biersack HJ (1991) Technetium-99m-HMPAO brain SPECT in medically intractable temporal lobe epilepsy: a postoperative evaluation. J Nucl Med 32:388–394

    PubMed  Google Scholar 

  • Hagglund J, Aquilonius SM, Eckernas SA, Hartvig P, Lundquist H, Gullberg P, Langstrom B (1987) Dopamine receptor properties in Parkinson’s disease and Huntington’s chorea evaluated by positron tomography using 11C-N-methylspiperone. Acta Neurol Scand 75:87–94

    CAS  PubMed  Google Scholar 

  • Hajek M, Antonini A, Leonhard K, Wieser HG (1993) Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology 43:79–86

    CAS  PubMed  Google Scholar 

  • Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Langstrom B, Sedvall G (1986) Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Appl Radiat Isot 37:1039–1043

    CAS  Google Scholar 

  • Halldin C, Farde L, Barnett A, Sedvall G (1990) Preparation of [11C]SCH 39166, a new selective D1 dopamine receptor ligand for PET. J Nucl Med 31:737

    Google Scholar 

  • Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J et al (1998) Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med 39:2061–2068

    CAS  PubMed  Google Scholar 

  • Hart J Jr., Lewis PJ, Lesser R, Fisher RS, Monsein LH, Schwerdt P, Bandeen-Roche K, Gordon B (1993) Anatomic correlates of memory from intracarotid amobarbital injections with technetium Tc-99m hexamethylpropyleneamine oxime SPECT. Arch Neurol 50:745–750

    PubMed  Google Scholar 

  • Hatazawa J, Ishiwata K, Itoh M, Kameyama M, Kubota K, Ido T, Matsuzawa T, Yoshimoto T, Watanuki S, Seo S (1989) Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography. J Nucl Med 30:1809–1813

    CAS  PubMed  Google Scholar 

  • Hatazawa J, Shimosegawa E, Okudera T, Inugami A, Ogawa T, Fujita H, Noguchi K, Kanno I, Miura S (1995) Evaluation of cerebral infarction with 123I-Iomazenil SPECT. J Nucl Med 36:2154–2161

    CAS  PubMed  Google Scholar 

  • Henry TR, Mazziotta JC, Engel J Jr, Christenson PD, Zhang JX, Phelps ME, Kuhl DE (1990) Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 10:748–757

    CAS  PubMed  Google Scholar 

  • Henry TR, Mazziotta JC, Engel J Jr (1992) The functional anatomy of frontal lobe epilepsy studied with PET. In: Chauvel P, Delgado-Escueta A, Holgren E, Bancaud J (eds) Advances in neurology, vol 57. Raven, New York, pp 449–463

    Google Scholar 

  • Herscovitch P, Markham J, Raichle ME (1983) Brain blood flow measured with intravenous H2150. I. Theory and error analysis. J Nucl Med 24:782–789

    CAS  PubMed  Google Scholar 

  • Hicks BW, Rogers GA, Parsons SM (1991) Purification and characterization of a nonvesicular vesamicol-binding protein from electric organ and demonstration of a related protein in mammalian brain. J Neurochem 57:509–519

    CAS  PubMed  Google Scholar 

  • Hietala S-O, Silfvenius H, Aasly J, Olivecrona M, Johnson L (1990) Brain perfusion with intracarotid injection of 99mTc-HM-PAO in partial epilepsy during amobarbital testing. Eur J Nucl Med 16:683–687

    Article  CAS  PubMed  Google Scholar 

  • Hoedt-Rasmussen L, Sveinsdottir E, Lassen NA (1966) Regional cerebral blood flow in man determined by intra-arterial injection of radioactive inert gas. Circ Res 18:237–247

    CAS  PubMed  Google Scholar 

  • Hornykiewicz O, Kish SJ (1984) Neurochemical basis of dementia in Parkinson’s disease. Can J Neurol Sci 11[Suppl 1]:185–190

    CAS  PubMed  Google Scholar 

  • Hornykiewicz O, Kish SJ (1986) Biochemical pathophysiology of Parkinson’s disease. Adv Neurol 45:19–34

    Google Scholar 

  • Iinuma K, Yokoyama H, Otsuki T, Yanai K, Watanabe T, Ido T, Itoh M (1993) Histamine H1 receptors in complex partial seizures. Lancet 341:238

    Article  CAS  PubMed  Google Scholar 

  • Ilgin N, Zubieta JK, Reich SG, Ravert TH, Dannals RF, Frost JJ (1995) Differential diagnosis of Parkinson’s disease and progressive supranuclear palsy with C11-WIN 35,248 PET imaging of the dopamine transporter. J Nucl Med 36:99

    Google Scholar 

  • Ingvar DH, Lassen NA (1961) Quantitative determination of regional cerebral blood flow in man. Lancet 2:806–807

    Google Scholar 

  • Innis RB, al-Tikriti MS, Zoghbi S, Baldwin RM, Sybirska EH, Laruelle MA, Malison RT, Seiby JP, Zimmermann RC, Johnson EW (1991) SPECT imaging of the enzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med 32:1754–1761

    CAS  PubMed  Google Scholar 

  • Irie T, Fukushi K, Namba H, Iyo M, Tamagami H, Nagatsuka S et al (1996) Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer’s disease. J Nucl Med 37:649–655

    CAS  PubMed  Google Scholar 

  • Iyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, Nagatsuka S, Sumara T, Sudo Y, Suzuki K, Irie T (1997) Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer’s disease. Lancet 349:1805–1809

    Article  CAS  PubMed  Google Scholar 

  • Jeffery PJ, Monsein LH, Szabo A, Hart JH, Fisher FS, Lesser RP, Debrun GM, Gordon B, Wagner HN Jr, Camargo EE (1991) Mapping the distribution of amobarbital sodium in the intracarotid Wada test by use of Tc-99m HMPAO with SPECT. Radiology 178:847–850

    CAS  PubMed  Google Scholar 

  • Jones AK, Luthra SK, Maziere B, Pike VW, Loc’h C, Crouzel C, Syrota A, Jones T (1988) Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers. J Neurosci Methods 2:121–129

    Google Scholar 

  • Jorgensen HS, Sperling B, Nakayama H, Raaschow HO, Olsen TS (1994) Spontaneous reperfusion of cerebral infarcts in acute stroke patients. Incidence, time course and clinical outcome: the Copenhagen Stroke study. Arch Neurol 57:865–873

    Google Scholar 

  • Kamo H, McGeer PL, Harrop R, McGeer EG, Calne DB, Martin WR, Pate BD (1987) Positron emission tomography and histopathology in Pick’s disease. Neurology 37:439–445

    CAS  PubMed  Google Scholar 

  • Kanno I, Lassen NA (1979) Two methods for calculation of regional cerebral blood flow from emission computed tomography of emission tomography of inert gas concentration. J Comput Assist Tomogr 3:71–76

    CAS  PubMed  Google Scholar 

  • Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL (1987) Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28:47–52

    CAS  PubMed  Google Scholar 

  • Kilbourn MR, Jung YW, Haka MS, Gildersleeve DL, Kuhl DE, Wieland DM (1990) Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sci 47:1955–1963

    Article  CAS  PubMed  Google Scholar 

  • Kilbourn MR, Snyder SE, Sherman PS, Kuhl DE (1996) In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). Synapse 22:123–131

    Article  CAS  PubMed  Google Scholar 

  • Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, Hawkins RA, and Becker DP. (1990) Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 31:965–969

    CAS  PubMed  Google Scholar 

  • Koepp MJ, Labbe C, Richardson MP, Brooks DJ, van Paesschen W, Cunningham VJ, Duncan JS (1997a) Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 120:1865–1876

    Article  PubMed  Google Scholar 

  • Koepp MJ, Richardson MP, Brooks DJ, Cunningham VJ, Duncan JS (1997b) Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study. Epilepsia 38:1089–1097

    Article  CAS  PubMed  Google Scholar 

  • Koepp MJ, Richardson MP, Brooks DJ, Duncan JS (1998) Focal cortical release of endogenous opioids during reading-induced seizures. Lancet 352:952–955

    Article  CAS  PubMed  Google Scholar 

  • Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee KS, Kuhl DE (1994) [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: Methodology and kinetic modeling alternatives. J Cereb Blood Flow Metab 14:85–99

    CAS  PubMed  Google Scholar 

  • Krausz Y, Cohen D, Konstantini S, Meiner Z, Yaffe S, Atlan H (1991) Brain SPECT imaging in temporal lobe epilepsy. Neuroradiology 33:274–276

    Article  CAS  PubMed  Google Scholar 

  • Krenning EP, Kwekkeboom DJ, Bakker WH, Breman WAP, Kooij PPM, Oei HJ, wan Haen M, Postema PTE, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ (1993) Somatostatin receptor scintigraphy with 111In-DTPA-D-Phe and 123I-Tyr3-octeotride: the Rotterdam experience in more than 1000 patients. Eur J Nucl Med 20:716–731

    Article  CAS  PubMed  Google Scholar 

  • Kuhl DE, Engel J Jr, Phelps ME, Selin C (1980) Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol 8:348–360

    CAS  PubMed  Google Scholar 

  • Kuhl DE, Metter EJ, Riege WH (1984) Patterns of local cerebral glucose utilisation determined in Parkinson’s disease by the 18F-fluorodeoxyglucose method. Ann Neurol 15:419–424

    CAS  PubMed  Google Scholar 

  • Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann RJ, Carey JE, Glidersleeve DL, Frey KA, Wieland DM (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 35:405–410

    CAS  PubMed  Google Scholar 

  • Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer’s disease, and Parkinson’s disease. Ann Neurol 40:339–410

    Article  Google Scholar 

  • Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL et al (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease. Neurology 52:691–699

    CAS  PubMed  Google Scholar 

  • Kung HF, Kasliwal R, Pan SG, Kung MP, Mach RH, Guo YZ (1988) Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)-and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide. J Med Chem 31:1039–1043

    Article  CAS  PubMed  Google Scholar 

  • Kung HF, Alavi A, Chang W, Kung MP, Keyes JW Jr, Velchik MG, Billings J, Pan S, Noto R, Rausch et al (1990) In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med 31:573–579

    CAS  PubMed  Google Scholar 

  • Kung MP, Stevenson DA, Plossl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF (1997) [99mTc] TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 24:372–380

    CAS  PubMed  Google Scholar 

  • Lamusuo S, Ruottinen HM, Knuuti J, Harkonen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jaaskelainen S, Ylinen A, Kalviainen R, Rinne JK, Vapalahti M, Rinne JO (1997) Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. J Neurol Neurosurg Psychiatry 63:743–748

    CAS  PubMed  Google Scholar 

  • Lang W, Podreka I, Suess E, Müller C, Zeitlhofer J, Deecke L (1988) Single photon emission computerized tomography during and between seizures. J Neurol 235:277–284

    Article  CAS  PubMed  Google Scholar 

  • Langen K (1997) Evaluation of 123-I-a-L-methyltyrosine as a SPECT tracer of amino acid uptake in brain tumours. In: De Deyn PP, Dierckx RA, Alavi A, Pickut BA (eds) SPECT in neurology and psychiatry. Libbey, London, pp 387–405

    Google Scholar 

  • Lassen NA (1966) The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet 2:1113–1115

    CAS  PubMed  Google Scholar 

  • Lee BI, Markand ON, Siddiqui AR, Park HM, Mock B, Wellman HH, Worth RM, Edwards MK (1986) Single photon emission computed tomography (SPECT) brain imaging using N,N,N‘-trimethyl-N‘-(2 hydroxy-3-methyl-5-123I-iodobenzil)-1,3-propanediamine 2 HCl (HIPDM): Intractable complex partial seizures. Neurology 36:1471–1477

    CAS  PubMed  Google Scholar 

  • Lee BI, Markand ON, Wellman HN, Siddiqui AR, Mock B, Krepshaw J, Kung H (1987) HIPDM single photon emission computed tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures. Epilepsia 28:305–311

    CAS  PubMed  Google Scholar 

  • Lee BI, Markand ON, Wellman HN, Siddiqui AR, Park HM, Mock B, Worth RM, Edwards MK, Krepshaw J (1988) HIPDM-SPECT in patients with medically intractable complex partial seizures. Arch Neurol 45:397–402

    CAS  PubMed  Google Scholar 

  • Lee KS, Frey KA, Koeppe RA, Buck A, Mulholland GK, Kuhl DE (1996) In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. J Cereb Blood Flow Metab 16:303–310

    CAS  PubMed  Google Scholar 

  • Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE et al (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease. Ann Neurol 47:493–503

    CAS  PubMed  Google Scholar 

  • Leenders KL, Aquilonius SM, Bergstrom K, Bjurling P, Crossman AR, Eckernas SA, Gee AG, Hartuing P, Lundtquist H, Langstrom B (1988) Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers. Brain Res 445:61–67

    Article  CAS  PubMed  Google Scholar 

  • Lenzi GL, Frackowiak RSJ, Jones T (1982) Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab 2:321–325

    CAS  PubMed  Google Scholar 

  • Leveille J, Demonceau G, Walovitch RC (1992) Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 33:480–484

    CAS  PubMed  Google Scholar 

  • Lever JR, Scheffel U, Stathis M, Seltzman HH, Wyrick CD, Abraham P, Parkam K, Thomas BF, Boja JW, Fuhar MJ, Carroll FI (1996) Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-[4-(125I)iodophenyl] tropan-2 beta-carboxylic acid isopropyl ester [(125I)RTI-121]. J Nucl Med Biol 23:277–284

    CAS  Google Scholar 

  • Limburg M, Royen EAV, Hijdra A, Verbeeten B Jr (1991) rCBFSPECT in brain infarction: When does it predict outcome. J Nucl Med 3:382–387

    Google Scholar 

  • Lucignani G, Losa M, Moresco RM, del Sole A, Matarrese M, Bettinardi V, Mortini P, Giovanelli M, Fazio F (1997) Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone. Eur J Nucl Med 24:1149–1155

    CAS  PubMed  Google Scholar 

  • Lundkvist C, Halldin C, Ginovart N, Nyberg S, Swahn CG, Carr AA, Brunner F, Farde L (1996) [11C]MDL 100907, a radioligand for selective imaging of 5-HT(2A) receptors with positron emission tomography. Life Sci 58:PL 187–192

    Article  CAS  Google Scholar 

  • Madar I, Lever JR, Kinter CM, Scheffel U, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ (1996) Imaging of delta opioid receptors in human brain by N1‘-([11C]methyl)naltrindole and PET. Synapse 24:19–28

    Article  CAS  PubMed  Google Scholar 

  • Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ (1997) Imaging of delta-and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol 41:358–367

    Article  CAS  PubMed  Google Scholar 

  • Maffioli L, Gasparini M, Chiti A, Gramaglia A, Mongoj V, Pozzi A, Bombardieri E (1996) Clinical role of thechnetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med 23:308–311

    Article  CAS  PubMed  Google Scholar 

  • Magistretti PL, Uren RF (1983) Cerebral blood flow patterns in epilepsy. In: Nistico G, DiPerri R, Meinardi H (eds) Epilepsy: an update on research and therapy. Liss, New York, pp 241–247

    Google Scholar 

  • Marek KL, Seibyl JP, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussell B, Charney DS, van Dyck C, Hoffer PB, Innis RP (1996) [123I] beta-CIT-SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson’s disease. Neurology 46:231–237

    CAS  PubMed  Google Scholar 

  • Markand ON, Salanova V, Worth R, Park HM, Wellman HN (1997) Comparative study of interictal PET and ictal SPECT in complex partial seizures. Acta Neurol Scand 95:129–136

    CAS  PubMed  Google Scholar 

  • Marks DA, Katz Am Hoffer P, Spencer SS (1992) Localization of extratemporal epileptic foci during ictal single photon emission computed tomography. Ann Neurol 31:250–255

    Article  CAS  PubMed  Google Scholar 

  • Martin WRW, Stoessl AJ, Palmer M, Adam MJ, Ruth TJ, Grierson JR et al (1988) Positron emission tomography in Parkinson’s disease: glucose and dopa metabolism. Adv Neurol 50:223–229

    CAS  PubMed  Google Scholar 

  • Martin WR, Palmer MR, Patlak CS, Calne DB (1989) Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 26:535–542

    Article  CAS  PubMed  Google Scholar 

  • Mason NS, Mathis CA (2003) Positron emission tomography radiochemistry. Neuroimag Clin North Am 13:671–687

    Google Scholar 

  • Mathis CA, Mahmood K, Huang Y, Simpson NR, Gerdes JM, Price JC (1996) Synthesis and preliminary in vivo evaluation of [11C]MDL 100907: a potent and selective radioligand for the 5-HT2A receptor system. Med Chem Res 6:1–10

    CAS  Google Scholar 

  • Mayberg HS, Sadzot B, Meltzer CC, Fisher RS, Lesser RP, Dannals RF, Lever JR, Wilson AA, Ravert HT, Wagner HN Jr, Bryan RN, Cromwell CC, Frost JJ (1991) Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 30:3–11

    Article  CAS  PubMed  Google Scholar 

  • Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, Grassi F, del Sole A, Franeschi M, Gilardi MC, Fazio F (1994) High resolution SPET/ [99mTc]HM-PAO in patients with probable Alzheimer’s disease: comparison with PET/ [18F]FDG. J Nucl Med 35:210–216

    CAS  PubMed  Google Scholar 

  • Messa C, Volonté MA, Fazio F, Zito F, Carpinelli A, d’Amico A, Rizzo G, Moresco RM, Paulesu E, Franceschi M, Lucignani G (1998) Differential distribution of striatal [123I]ßCIT in Parkinson’s disease and progressive supranuclear palsy, evaluated with SPET. Eur J Nucl Med 25:1270–1276

    Article  CAS  PubMed  Google Scholar 

  • Meyer M, Koeppe A, Frey KA, Foster NL, Kuhl DE (1995) Positron emission tomography measures of benzodiazepine binding in Alzheimer’s disease. Arch Neurol 52:314–317

    CAS  PubMed  Google Scholar 

  • Miletich RS, Chan T, Gillespie M et al (1988) Contralateral basal ganglia metabolism in abnormal in hemiparkinsonian patients. An FDG-PET study. Neurology 38:S260

    Google Scholar 

  • Miller BL, Darby A, Benson DF, Cummings JL, Miller MH (1997) Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry 170:150–154

    CAS  PubMed  Google Scholar 

  • Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18FDG PET. J Nucl Med 36:1238–1248

    CAS  PubMed  Google Scholar 

  • Mueller-Gaertner HW, Mayberg HS, Fisher RS, Lesser RP, Wilson AA, Ravert HT, Dannals RF, Wagner HN, Uematsu S, Frost JJ (1993) Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and SPECT in epilepsy. Ann Neurol 34:235–238

    Google Scholar 

  • Muhr C, Bergstrom M, Lundberg PO, Bergstrom K, Hartving P, Lundqvist H, Antoni G, Langstom B (1986) Dopamine receptors in pituitary adenomas: PET visualization with (11C)-N-methyl-spiperone. J Comput Assist Tomogr 10:175–180

    CAS  PubMed  Google Scholar 

  • Mulholland GK, Otto CA, Jewett DM, Kilbourn MR, Koeppe RA, Sherman PS, Petry NA, Carey JE, Atkinson ER, Archer S, Frey KA, Kuhl DE (1992) Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11 labeled (+)-2a-tropanyl benzilate: a central muscarinic receptor imaging agent. J Nucl Med 33:423–430

    CAS  PubMed  Google Scholar 

  • Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE (1995) Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nucl Med Biol 22:13–17

    CAS  PubMed  Google Scholar 

  • Nadeau SE, Couch MW, Devane CL, Shukla SS (1995) Regional analysis of D2 dopamine receptors in Parkinson’s disease using SPECT and iodine-123-iodobenzamide. J Nucl Med 36:384–393

    CAS  PubMed  Google Scholar 

  • Nahmias C, Garnett ES, Firnau G, Long A (1985) Striatal dopamine distribution in parkinsonian patients during life. J Neurol Sci 69:223–230

    Article  CAS  PubMed  Google Scholar 

  • Namba H, Irie T, Fukushi K, Iyo M (1994) In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog. Brain Res 667:278–282

    Article  CAS  PubMed  Google Scholar 

  • Neumeyer JL, Wang S, Milius RA, Baldwin RM, Zea Ponce Y, Hoffer PB, Sybirska E, al Tikriti M, Charney DS, Malison RT (1991) Iodine-123-2-β-carboxymethoxy-3-β-(4-iodophenyl)tropane (βCIT): high affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 34:3144–3146

    CAS  PubMed  Google Scholar 

  • Newton MR, Berkovic SF, Austin MC, Reutens DC, McKay WJ, Bladin PF (1992) Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology 42:371–377

    CAS  PubMed  Google Scholar 

  • O’Brien TJ, Zupanc ML, Mullan BP, O’Connor MK, Brinkmann BH, Cicora KM, So EL (1998) The practical utility of performing peri-ictal SPECT in the evaluation of children with partial epilepsy. Pediatr Neurol 19:15–22

    CAS  PubMed  Google Scholar 

  • Obrist WD, Thompson HK Jr, Wang KS, Wilkinson WE (1975) Regional cerebral blood flow estimated by 133-Xenon inhalation. Stroke 6:245–256

    CAS  PubMed  Google Scholar 

  • Otsuka M, Ichiya Y, Hosokawa S (1991) Striatal blood flow, glucose metabolism, and 18F-dopa uptake: difference in Parkinson’s disease and atypical parkinsonism. J Neurol Neurosurg Psychiatry 54:898–904

    CAS  PubMed  Google Scholar 

  • Patlak C, Blasberg R, Fenstermacher J (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584–590

    CAS  PubMed  Google Scholar 

  • Perlmutter JS, Raichle ME (1985) Regional blood flow in hemiparkinsonism. Neurology 35:1127–1134

    CAS  PubMed  Google Scholar 

  • Persson A, Ehrin E, Eriksson L, Farde L, Hedstrom CG, Litton JE, Mindus P, Sedvall G (1985) Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 19:609–622

    Article  CAS  PubMed  Google Scholar 

  • Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-dglucose: validation of method. Ann Neurol 6:371–388

    Article  CAS  PubMed  Google Scholar 

  • Podruchny TA, Connolly C, Bokde A, Herscovitch P, Eckelman WC, Kiesewetter DO et al (2003) In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers. Synapse 48:39–44

    Article  CAS  PubMed  Google Scholar 

  • Pirker W, Riedl M, Luger A, Czech T, Rossler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brucke T (1996) Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT. J Nucl Med 37:1931–1937

    CAS  PubMed  Google Scholar 

  • Price JC (2003) Principles of tracer kinetic analysis. Neuroimag Clin North Am 13:689–704

    Google Scholar 

  • Ramsey SC, McLaughlin AF, Greenough R, Walsh J, Morris JG (1992) Comparison of independent aura, ictal and interictal cerebral perfusion. J Nucl Med 33:438–440

    Google Scholar 

  • Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavia A, Som P, Sokoloff L (1979) The 18F-Fluoro-deoxyglucosemethod for the measurement of local cerebral glucose utilization in man. Circ Res 44:127–137

    CAS  PubMed  Google Scholar 

  • Ricci M, Pantano P, Pieralini A, di Stefano D, Santoro A, Bozzao L, Lenzi GL (1996) Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 23:524–529

    CAS  PubMed  Google Scholar 

  • Richardson MP, Friston KJ, Sisodiya SM, Koepp MJ, Ashburner J, Free SL, Brooks DJ, Duncan JS (1997) Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain 120:1961–1973

    Article  PubMed  Google Scholar 

  • Richardson MP, Koepp MJ, Brooks DJ, Duncan JS (1998) 11C-flumazenil PET in neocortical epilepsy. Neurology 51:485–492

    CAS  PubMed  Google Scholar 

  • Rinne JO, Laihinen A, Nagren K, Bergman J, Ruotsalainen U, Rinne UK (1990) PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson’s disease. J Neurosci Res 27:494–499

    Article  CAS  PubMed  Google Scholar 

  • Risinger MW, Engel J Jr, van Ness PL, Henry TR (1989) Ictal localization of temporal lobe seizures with scalp/sphenoidal recordings. Neurology 39:1288–1293

    CAS  PubMed  Google Scholar 

  • Robitaille Y, Rasmussen T, Dubeau, Tampieri D, Kemball K (1992) Histopathology of non-neoplastic lesions in frontal lobe epilepsy. Review of 180 cases with recent MRI and PET correlations. In: Chauvel P, Delgado-Escueta A, Holgren E, Bancaud J (eds) Advances in neurology, vol 57. Raven, New York, pp 499–513

    Google Scholar 

  • Rowe CC, Berkovic SF, Sia STB, Austin M, McKay WJ, Kalnins RM, Bladin PF (1989) Localization of epileptic foci with postictal single photon emission computed tomography. Ann Neurol 26:660–668

    Article  CAS  PubMed  Google Scholar 

  • Rowe CC, Berkovic SF, Austin MC, McKay WJ, Bladin PF (1991a) Patterns of postictal cerebral blood flow in temporal lobe epilepsy: qualitative and quantitative analysis. Neurology 41:1096–1103

    CAS  PubMed  Google Scholar 

  • Rowe CC, Berkovic SF, Austin MC, Saling M, Kalnins RM, McKay WJ, Bladin PF (1991b) Visual and quantitative analysis of interictal SPECT with technetium-99m-HMPAO in temporal lobe epilepsy. J Nucl Med 32:1688–1694

    CAS  PubMed  Google Scholar 

  • Ryding E, Rosen I, Elmqvist B, Ingvar DH (1988) SPECT measurements with 99mTc-HMPAO in focal epilepsy. J Cereb Blood Flow Metab 8:S95–S100

    CAS  PubMed  Google Scholar 

  • Ryvlin P, Garcia-Larrea L, Philippon B, Froment JC, Fischer C, Revol M, Mauguière F (1992) High signal intensity on T2-weighted MRI correlates with hypoperfusion in temporal lobe epilepsy. Epilepsia 33:28–35

    Article  CAS  PubMed  Google Scholar 

  • Sabatini U, Celsis P, Viallard G, Rascol A, Marc Vergnes JP (1991) Quantitative assessment of cerebral blood volume by single-photon emission computed tomography. Stroke 22:324–330

    CAS  PubMed  Google Scholar 

  • Sackellares JC, Siegel GJ, Abou-Khalil BW, Hood TW, Gilman S, McKeever PE, Hichwa RD, Hutchins GD (1990) Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 40:1420–1426

    CAS  PubMed  Google Scholar 

  • Salanova V, Markand O, Worth R, Smith R, Wellman H, Hutchins G, Park H, Ghetti B, Azzarelli B (1998) FDG-PET and MRI in temporal lobe epilepsy: relationship to febrile seizures, hippocampal sclerosis and outcome. Acta Neurol Scand 97:146–153

    CAS  PubMed  Google Scholar 

  • Samson Y, Hantraye P, Baron JC, Soussaline F, Comar D, Maziere M (1985) Kinetics and displacement of 11C-Ro 15=1788, a benzodiazepine antagonist, studied in human brain in vivo by positron emission tomography. Eur J Pharmacol 110:247–251

    Article  CAS  PubMed  Google Scholar 

  • Sanabria E, Chauvel P, Askienazy S, Vignal JP, Trottier S, Chodkiewicz JP, Bancaud J (1983) Single photon emission computed tomography (SPECT) using 123I-isopropyl-iodoamphetamine (IAMP) in partial epilepsy. In: Baldy-Moulinier M, Ingar D-H, Meldrum BS (eds) Current problems in epilepsy. vol 1. Cerebral blood flow, metabolism and epilepsy. Libbey, London, pp 82–87

    Google Scholar 

  • Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L (1988) In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2:863–866

    CAS  PubMed  Google Scholar 

  • Savic I, Widen L, Thorell JO, Blomqvist G, Ericson K, Roland P (1990) Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia 31:724–730

    CAS  PubMed  Google Scholar 

  • Savic I, Ingvar M, Stone-Elander S (1993) Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 56:615–621

    CAS  PubMed  Google Scholar 

  • Savic I, Blomqvist G, Halldin C, Litton JE, Gulyas B (1998) Regional increases in [11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 97:279–286

    CAS  PubMed  Google Scholar 

  • Scheffel U, Dannals RF, Wong DF, Yokoi F, Carroll FI, Kuhar MJ (1992) Dopamine transporter imaging with novel, selective cocaine analogs. Neuroreport 3:969–972

    CAS  PubMed  Google Scholar 

  • Scheffel U, Horti AG, Koren AO, Ravert HT, Banta JP, Finley PA et al( 2000) 6-[18F]Fluoro-A-85380: an in vivo tracer for the nicotinic acetylcholine receptor. Nucl Med Biol 27:51–56

    CAS  PubMed  Google Scholar 

  • Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL (1994) Comparison of 123I-IBZM SPECT and 11Craclopride PET findings in patients with parkinsonism. Nucl Med Commun 15:806–813

    CAS  PubMed  Google Scholar 

  • Seibyl J, Wallace, Smith E et al (1994) Whole body biodistribution, radiation absorbed dose, and brain SPECT imaging with [123I]ß-CIT in healthy human subjects. J Nucl Med 35:764–770

    CAS  PubMed  Google Scholar 

  • Serrati C, Marchal G, Rioux P, Viader F, Petit Taboue MC, Lochon P, Luet D, Derlon JM, Baron JC (1994) Contralateral cerebellar hypometabolism: a predictor for stroke outcome? J Neurol Neurosurg Psychiatry 57:174–179

    CAS  PubMed  Google Scholar 

  • Shinotoh H, Yamasaki T, Inoue O, Itoh T, Suzuki K, Hashimoto K, Tateno Y, Ikehira H (1986) Visualization of specific binding sites of benzodiazepine in human brain. J Nucl Med 27:1593–1599

    CAS  PubMed  Google Scholar 

  • Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10:24–35

    PubMed  Google Scholar 

  • Shulkin BL (1997) PET applications in pediatrics (review) (20 refs). Q J Nucl Med 41:281–291

    CAS  PubMed  Google Scholar 

  • Siegel GJ, Agranoff BW, Wayne Albers R, Fisher SK, Uhler MD (1999) Basic Neurochemistry. Molecular, cellular and medical aspects, 6th edn. Lippincott-Raven, Philadelphia

    Google Scholar 

  • Sokoloff L (1960) The metabolism of the central nervous system in vivo. In: Field J, Magoun HW, Hall VE (eds) Handbook of physiology-neurophysiology, vol 3. American Physiological Society, Washington DC, pp 1843–1864

    Google Scholar 

  • Soler C, Beauchesne P, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, Brunon J (1998) Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25:1649–1657

    Article  CAS  PubMed  Google Scholar 

  • Soucy JP, McNamara D, Mohr G, Lamoureux F, Lamoureux J, Danais S (1990) Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethylpropyleneamine oxime (HM-PAO) tomoscintigraphy. J Nucl Med 31:972–977

    CAS  PubMed  Google Scholar 

  • Stefan H, Kuhnen C, Biersack HJ, Reichmann K (1987) Initial experience with 99mTc hexamethyl-propylene amine oxime (HM-PAO) single photon emission computed tomography (SPECT) in patients with focal epilepsy. Epilepsy Res 1:134–138

    Article  CAS  PubMed  Google Scholar 

  • Stefan H, Pawlik G, Böcher-Schwarz HG, Biersack HJ, Burr W, Penin H, Heiss W-D (1987) Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. J Neurol 234:377–384

    Article  CAS  PubMed  Google Scholar 

  • Swartz BE, Halgren E, Delgado-Escueta AV, Mandelkern M, Gee M, Quinones N, Blahd WH, Repchan J (1989) Neuroimaging in patients with seizures of probable frontal lobe origin. Epilepsia 30:547–558

    CAS  PubMed  Google Scholar 

  • Swartz BE, Theodore WH, Sanabria E, Fisher RS (1992a) Positron emission and single photon emission computed tomographic studies in the frontal lobe with emphasis on the relationship to seizure foci. In: Chauvel P, Delgado-Escueta A, Holgren E, Bancaud J (eds) Advances in neurology, vol 57. Raven, New York, pp 487–497

    Google Scholar 

  • Theodore WH, Newmark ME, Sato S, de LaPaz R, DiChiro G, Brooks R, Patronas N, Kessler RM, Manning R, Margolin R, Channing M, Porter RJ (1984) 18F-fluorodoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol 14:429–437

    Google Scholar 

  • Theodore WH, Fishbein D, Dubinsky R (1988) Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology 38:1201–1206

    CAS  PubMed  Google Scholar 

  • Thomas P, Migneco O, Darcourt J, Chatel M (1992) Single photon emission computed tomography study of subclinical rhythmic electrographic discharge in adults. Electroencephalogr Clin Neurophysiol 83:223–227

    CAS  PubMed  Google Scholar 

  • Uhl GR, Hedreen JC, Price DL (1985) Parkinson’s disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology 35:1215–1218

    CAS  PubMed  Google Scholar 

  • Van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG (1993) Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 50:513–516

    PubMed  Google Scholar 

  • Vorstrup S, Brun B, Lassen NA (1986) Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusions of the internal carotid artery. Stroke 17:1291–1298

    CAS  PubMed  Google Scholar 

  • Wagner HNJ, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AV, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron emission tomography. Science 221:1264–1266

    CAS  PubMed  Google Scholar 

  • Wise RJS, Bernardi S, Frackowiak RSJ, Legg NJ, Jones T (1983) Serial observations on the pathophysiology of acute stroke: the transition from ischemia to infarction as reflected in regional oxygen extraction. Brain 106:197–222

    PubMed  Google Scholar 

  • Wolfson LI, Leenders KL, Brown LL, Jones T (1985) Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology 35:1399–1405

    CAS  PubMed  Google Scholar 

  • Yamamoto YL, Ochs R, Gloor P, Ammann W, Meyer E, Evans AC, Cooke B, Sako K, Gotman J, Feindel WH, Diksic M, Thompson CJ, Robitaille Y (1983) Patterns of rCBF and focal energy metabolic changes in relation to electroencephalographic abnormality in the interictal phase of partial epilepsy. In: Baldy-Moulinier M, Ingvar D-H, Meldrum BS (eds) Current problems in epilepsy, vol 1. Cerebral blood flow, metabolism and epilepsy. Libbey, London, pp 51–62

    Google Scholar 

  • Zubieta JK, Frey KA, Koeppe RA, Kilbourn MR, Mulholland GK, Foster NL et al (1994) Muscarinic receptor binding in aging and Alzheimer’s disease determined with [11C]nmethyl-4-piperidyl benzilate and PE. J Nucl Med 35[Suppl 5]:20P

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Molecular Imaging, Division of Radiation Oncology, European Institute of Oncology, and Institute of Radiological Sciences, University of Milan, Via Ripamonti 435, 20141, Milan, Italy

    Giovanni Lucignani MD

  2. Departments of Radiology and Radiological Services and Neuroscience, The Johns Hopkins University School of Medicine, JHOC 3225, 601 North Carolina Street, Baltimore, MD, 21287, USA

    James J. Frost PhD, MD

Authors
  1. Giovanni Lucignani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James J. Frost PhD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Leuven, Germany

    A. L. Baert

  2. Heidelberg, Germany

    K. Sartor

  3. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, AR-144 CHS, Los Angeles, CA, 90095-6942, USA

    Christiaan Schiepers MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lucignani, G., Frost, J.J. (2006). Neurochemical Imaging with Emission Tomography: Clinical Applications. In: Baert, A.L., Sartor, K., Schiepers, C. (eds) Diagnostic Nuclear Medicine. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30005-8_2

Download citation

  • DOI: https://doi.org/10.1007/3-540-30005-8_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42309-6

  • Online ISBN: 978-3-540-30005-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation